You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics for the modified intent to treat population.

From: Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

Characteristic n (%)
Total treated 418
Gender 241 (57.7)
   Male 177 (42.3)
   Female  
Age, years 45.0 [13–92]
   Median range  
   < 65 362 (86.6)
   ≥ 65 56 (13.4)
BMI 417
   Mean ± SD 26.9 ± 6.9
Smoking status  
   Smoker 160 (38.3)
   Ex-smoker 79 (18.9)
   Nonsmoker 179 (42.8)
Chest x-ray findings  
   Unilateral 304 (73.6)
   Bilateral 109 (26.4)
   Single lobe* 351 (85.0)
   Multiple lobe 54 (13.1)
   Pleural effusion 15 (3.6)
   Bacteremia 15 (3.6)
S pneumoniae bacteremia 9 (2.2)
Investigator assessment of current episode  
   Mild 93 (22.2)
   Moderate 279 (66.7)
   Severe 46 (11.0)
PSI  
   Class I 222 (53.1)
   Class II 144 (34.4)
   Class III 39 (9.3)
   Class IV 12 (2.9)
   Class V 1 (0.2)
  1. BMI = body mass index; PSI = pneumonia severity index; SD = standard deviation.
  2. *"Single lobe" could apply to either unilateral or bilateral lung involvement (i.e. 1 lobe per right and/or left lung).